Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 405.85
-7.95 (-1.92%)
Jun 19, 2026, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 155.26 billion as of June 18, 2026. Its market cap has decreased by -61.26% in one year.
Market Cap
155.26B
Enterprise Value
157.24B
Revenue
22.69B
Ranking
n/a
PE Ratio
86.72
Stock Price
405.85
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 155.26B, an increase of 460,558.28%. That is a compound annual growth rate of 282.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 155.26B | -23.22% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 332.39B |
| Wockhardt | 323.23B |
| Piramal Pharma | 212.72B |
| Eris Lifesciences | 198.23B |
| NATCO Pharma | 158.24B |
| Alembic Pharmaceuticals | 147.36B |
| Alivus Life Sciences | 130.10B |
| Strides Pharma Science | 102.39B |